- Shipment
of medical cannabis to Israel represents a new international revenue
opportunity for Supreme Cannabis
- Truverra-branded
product will be sold through Israel’s largest and leading producer of
medical cannabis and cannabis product
- The
cannabis was grown at Supreme Cannabis’ premium, indoor, hybrid
cultivation operation located in Ontario
The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF)
(FRA: 53S1), a company dedicated to growing the world’s best cannabis and
becoming a leader in the global cannabis industry, completed a landmark
shipment of medical cannabis from Canada to Israel. The shipment contained
Supreme Cannabis’ premium medical cannabis product, which will be sold through
Israel’s largest and leading producer of medical cannabis and cannabis
product (http://ibn.fm/mocwy).
Supreme Cannabis interim president and CEO Colin Moore
reported that the transaction, which was made possible through a partnership
with Breath of Life International (BOL Pharma), represents a new international
revenue opportunity for Supreme Cannabis and “builds Truverra’s global medical
brand in one of the most sophisticated medical cannabis markets in the world.”
“With the support of BOL Pharma, we navigated both Canada
and Israel’s complex regulatory landscapes to achieve compliance with
regulatory authorities in both countries, including Health Canada, the Canadian
Food Inspection Agency and Israel’s Ministry of Health and Ministry of
Agriculture and Rural Development,” Moore continued. “We benefitted from BOL
Pharma’s skilled team, international experience and solidified position as a
leading medical cannabis company in Israel. As we pursue capital-light
international opportunities, we will continue to look to Jeff Adams, Truverra’s
CEO, and his exceptional team to build Truverra’s medical brand globally.”
Supreme Cannabis’ partner in Israel, BOL Pharma has been
researching and developing cannabis-based products for more than a decade and
is the only company in Israel that handles all stages of cultivation and
production, ensuring compliance with the strictest standards set by the Israeli
Ministry of Health and EU-GMP conditions.
Supreme Cannabis is exporting a differentiated offering to
Israel. Truverra’s premium positioned medical product is indoor grown and
distributed in 10-gram containers to BOL Pharma’s network of pharmacies across
Israel. BOL Pharma’s CEO, Dr. Tamir Gedo, spoke to the strength of Supreme
Cannabis as a partner and the quality of its product, noting, “Supreme Cannabis
is a partner that shares our high standards for quality and respect for
patients and consumers. On March 30, Truverra products became available across
pharmacies in Israel, and we are already receiving positive feedback from
patients. We look forward to continuing to work with Supreme Cannabis and to
offering Truverra’s premium medical cannabis to patients in Israel.”
Supreme Cannabis acquired Truverra last year in an agreement
designed to secure an international medical brand and strong team with unique
pharmaceutical expertise (http://ibn.fm/yODmc).
The Truverra acquisition provided a capital-light entry point into Europe’s CBD
wellness market, where Truverra had successfully launched multiple CBD products
through its ecommerce business, Truverra.com. This landmark shipment to Israel helps to
establish Truverra as an international medical cannabis brand and provides
diversified revenue opportunities for Supreme Cannabis.
The Supreme Cannabis Company is a global, diversified
portfolio of distinct cannabis companies, products and brands. Since 2014,
SPRWF has emerged as one of the world’s fastest-growing, premium plant-driven
lifestyle companies. Supreme Cannabis’ brands are backed by a focused suite of
world-class operating assets that serve key functions in the value chain,
including scaled cultivation, value-add processing, centralized manufacturing
and product testing and research and development.
For more information, visit the company’s website at www.Supreme.ca
NOTE TO INVESTORS: The latest news and updates
relating to SPRWF are available in the company’s newsroom at http://ibn.fm/SPRWF
About QualityStocks
QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential. We offer several ways for investors to learn more
about investing in these companies as well as find and evaluate them.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment